Author Login IJIRT Partner Network (IPN) Login

Anticancer Activity of Magnetic Iron Oxide Nanoparticles Synthesized Using Anacardium Occidentale Leaf Extract

  • Unique Paper ID: 157388
  • Volume: 9
  • Issue: 6
  • PageNo: 4-9
  • Abstract:
  • Iron Oxide nanoparticles were synthesized using extract of Anacardium Occidentale leaves which act as reducing as well as capping agents, and Ferric Chloride as a precursor. The Iron Oxide nanoparticles have been characterized using UV-Visible, FT-IR, SEM, TEM, EDAX and X-Ray diffraction studies. Anticancer activity of Iron Oxide nanoparticles was carried out against breast cancer cell (MDA-MB-231) and Skin cancer (SKMEL) cell lines. MTT assay identified significant anticancer activity of the nanoparticles against both cell lines. The result has shown that the Iron nanoparticles are crystalline with sizes ranging from 15 to 20 nm. Dose dependant reduction in cell viability were observed in breast cancer cell (MDA-MB-231) and Skin cancer (SKMEL) cells with different concentrations of the Iron Oxide nanoparticles. Viability percentage were reducing significantly and the IC50 value of Iron Oxide nanoparticles against Skin cancer cells were found to exhibit 35.35 µg/ml. This present study revealed that the successful green synthesis and characterization of Iron Oxide nanoparticles having excellent anticancer activities.
email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 6
  • PageNo: 4-9

Anticancer Activity of Magnetic Iron Oxide Nanoparticles Synthesized Using Anacardium Occidentale Leaf Extract

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry